Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn:
”We’re excited to see the Novartis Foundation and Novo Nordisk join forces to tackle cardiometabolic risk in cities.
Our new collaboration will combine insights and proven approaches from the two leading urban health programmes CARDIO 4 Cities (Novartis Foundation and Cities for Better Health (Novo Nordisk).
Initially launching in two European capitals, the goal is to build scalable models using practical tools, real-time data and catalytic funding to scale prevention and strengthen health systems in many more cities.
By working together, our collaboration has the potential to create lasting impact on urban health and social inequities.
Learn more:
Stay updated with Hemostasis Today.
-
Mar 10, 2026, 14:33Eugene Tang: A Look at What’s Happening in Life After Stroke Research Across Europe at ELASF 2026
-
Mar 10, 2026, 14:25Ahd Elmahi: Complex Case of Catecholamine-Induced Multiorgan Failure and Arterial Thrombosis in Community-Acquired Pneumonia
-
Mar 10, 2026, 13:36Nirupama Yechoor: How Survivors of Stroke Define Spiritual Wellbeing in Recovery
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer